Nàdarra Ventures is thrilled to announce our first investment in the transformative Food-as-Medicine sector, leading Sperri’s seed financing investment round with a $1.1M investment.
Sperri, a Halifax-based company innovator with national distribution, is Canada's first organic and allergen-free plant-based meal replacement beverage, poised to expand into the U.S. this year.
At Nadarra Ventures, we believe in supporting impact-driven sustainable solutions that address the critical needs of our food and health systems. Spearheaded by Gregg Curwin (President & CEO of Novagevity) and Dr. Mary Lynch (pain management specialist), Sperri’s mission is to make meal replacements that are both nutritious and accessible to those who need them most.
As food continues to be a cornerstone of health, Sperri is making waves, offering alternatives that are free from processed sugars, dairy, gluten, and soy protein. Their products aim to not only support wellness but also relieve pressure on healthcare systems by providing effective medical nutrition.
We're proud to join forces with Invest Nova Scotia and other independent investors in backing this visionary company as they expand their reach across North America.
The future of healthcare is here, and it starts with the food we eat
